Abstract
Pregnant Wistar strain albino rats were administered hydroxyprogesterone and the steroidogenic potential of the testis was analysed in the next generation adult male rats. In utero exposure to supranormal levels (10 mg/kg body weight or 25 mg/kg body weight) of hydroxyprogesterone decreased the activity levels of marker steroidogenic enzymes (3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase) of adult (mature) rat testis. Hydroxyprogesterone mediation in the suppression of rat testicular steroidogenesis is suggested, which can be correlated to the observed decrease in male reproductive potential in mammals exposed to female hormones during embryonic development.
References
Ancel PE, Bennett V, Bull D, Jackson MB, Pike LA, Pike MC, Chilvers CED, Dudle NE, Gouch MH, Griffiths DM (1992) Cryptorchidism: a prospective study of 7,500 consecutive male births: 1984–1988. Arch Dis Child 67:892–899
Beard M, Melton LJ, O'Fallon WM, Noller KL, Bensen RC (1984) Cryptorchidism and maternal estrogen exposure. Am J Epidemiol 120:707–716
Bergmeyer HU (1974) β-Hydroxysteroid dehydrogenase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 447–489
Brown LM, Potter LM, Hoover RN (1986) Prenatal and perinatal risk factors for testicular cancer. Cancer Res 46:4812–4816
Carlsen E, Giwercman A, Keiding N, Skakkebaek NE (1992) Evidence for decreasing quality of semen during past 50 years. Br Med J 304:609–613
Chengamma C, Reddanna P (1987) Effect of antispermatogenic agents on kinetic studies of 3 β-hydroxy steroid dehydrogenase. Indian J Exp Biol 25:506–509
Depue RH, Pike MC, Hendersen BE (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71:1151–1155
Farrow S (1994) Falling sperm quality: fact or fiction? Br Med J 309:1–2
Forman D, Moller H (1994) Testicular cancer. Cancer Surv 19/20:323–341
Hendersen BE, Benton B, Jing J, Yu MC, Pike MC (1979) Risk factors for cancer of the testis in young men. Int J Cancer 23:598–602
Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, Miller R, Moore J, Rolland R, Scott G, Sheehan DM, Sinks T, Tilson HA (1996) Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the US EPA-sponsored workshop. Environ Health Prospect 104:715–740
Liang AP, Levenson AG, Layde PM, Shelton JD, Hatcher RA, Potts M, Michelson MJ (1983) Risk of breast, uterine corpus and ovarian cancer in women receiving medroxyprogesterone injection. J Am Med Assoc 249:2909–2912
Matlai P, Beral V (1985) Trends in congenital malformations of external genitalia. Lancet 1:108
Merril RM, Brawley OW (1997) Prostate cancer incidence and mortality rates among whites and black men. Epidemiology 8:126–131
Palmlund I, Apfel R, Buitendijk S, Cabau A, Forsberg JG (1993) Effect of diethylstilbestrol (DES) medication during pregnancy. J Psychosom Obstet Gynaecol 14:71–89
Pillai SK, Sinha HC (1968) Statistical methods for biological workers. Ram Prasad, Agra, India
Quinn M, Allen E (1995) Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. Br Med J 311:1391–1395
Rothman KJ, Louik C (1978) Oral contraceptives and birth defects. New Eng J Med 299:522–524
Saal FS vom, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, Dhar MD, Ganjam VK, Parmigiani S, Welshons WV (1997) Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 94:2056–2061
Schumacher GFB, Gill WB, Hubby MM, Bluogh RR (1981) Semen analysis in males exposed in utero to diethylstilbestrol (DES) or placebo. Reprod Obstet Gynecol 9:100–101
Sharpe RM, Skakkebaek NE (1993) Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392–1395
Thayer KA, Ruhlen RL, Howdeshell KL, Buchanan D, Cooke PS, Welshons WV, vom Saal FS vom (2001) Altered reproductive organs in male mice exposed prenatally to sub-clinical doses of 17a-ethinyl estradiol. Hum Reprod 16:988–996
Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ, Jegou B, Jensen TK, Jouannet P, Keiding N, Leffers H, McLachlan JA, Meyer O, Muller J, Meyts ER, Scheike T, Sharpe R, Sumpter J, Skakkebaek NE (1996) Male reproductive health and environmental xenoestrogens. Environ Health Prospect 104:741–803
Wiebe JP (1969) Steroid dehydrogenases and steroids in gonads of the seaperch Cymatogaster aggregate Gibbons. Gen Comp Endocrinol 12:256–266
Yasuda Y, Kihara T, Tanimura T (1985) Effect of ethinyl estradiol on the differentiation of mouse fetal testis. Tera 32:113–118
Yasuda Y, Kihara T, Tanimura T (1986) Leydig cell hyperplasia in fetal mice treated transplacentally with ethinyl estradiol. Tera 33:281–288
Yasuda Y, Obura I, Konishi H (1988) Long term effects on male reproductive organs of prenatal exposure to ethinyl estradiol. Am J Obstet Gynecol 159:1246–1250
Acknowledgements
We are grateful to Mrs. B. Manjulatha Reddy, Mr. S. Umasankar and Mr. K. Chakrapani for their help in preparing the manuscript. This research was supported financially by the University Grants Commission, New Delhi to P.S.R. in the form of research grant (F-3-54/99). Sri Venkateswara University Ethical Committee approved all the experiments conducted using the rat model, and the present research complies with the laws of the country.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pushpalatha, T., Reddy, P.R. & Reddy, P.S. Effect of prenatal exposure to hydroxyprogesterone on steroidogenic enzymes in male rats. Naturwissenschaften 90, 40–43 (2003). https://doi.org/10.1007/s00114-002-0384-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00114-002-0384-1